藥品研發人員 的英文怎麼說

中文拼音 [yàopǐnyánfārényuán]
藥品研發人員 英文
pharma - r&d
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 品 : Ⅰ名詞1 （物品） article; product 2 （等級; 品級） grade; class; rank 3 （品質） character; qualit...
  • 研 : 研同 「硯」
  • 發 : 名詞（頭發） hair
  • 員 : 員名詞1. （指工作或學習的人） a person engaged in some field of activity 2. （指團體或組織中的成員） member Ⅱ量詞（用於武將）
  • 藥品 : drug; medicinal; medicines and chemical reagents; pharmaceutical
  • 研發 : ipd
  1. At his instigation, pfizer ' s secretive boffins unveiled details of the firm ' s drugs pipeline, disclosing information for the first time on more than half of its 30 research programmes

    在他的鼓勵下，輝瑞的幕後研究人員在活動中透露了公司許多研發中藥品的細節，首次披露了其30個研發項目中過半項目的信息。
  2. Dwt series dryer for vegetable dehydration os special equipment researched and developed on the basis of traditional net belt dryer, it has stronger pertinency, practicability and high efficirency of energy, it is whde used for all kinds of vegetables dehydration such as garlic, cushaw, giantarum, white turnip, yam, bamboo shoot, dtc at different region and season, our factory has more 50 of customers and more 80 of production line in cooperation. our factory is an enterprise with the richest experience to manufacture dryer for vegetables dehydration, the technicians of our factory

    Dwt脫水乾燥機是在傳統網帶式乾燥機基礎上研究開發的專用型設備，具有較強的針對性、實用性，能源效率高，廣泛適用於各種地區性和季節性蔬菜、果品的脫水乾燥，如：蒜片、南瓜、魔芋、白蘿卜、山藥、竹筍等，已擁有用戶50多家，在線設備80多臺套，是國內最富經驗的蔬菜乾燥設備生產企業，工廠科技人員長期跟蹤服務于這些用戶。
  3. Prepared chitosan products, developed by our research & developing center, won the golden cup of " blue cross " awarded by marine medicine professional committee of china medicine institute and medication branch of china marine lacustrine bog institute in 1994, and won international golden medal of " 1996 gold autumns international fine work, best selling goods and technological fair " international honor committee of invention center of academy of sciences of macao in 1996

    我公司科研人員研製開發的殼聚糖系列產品， 1994年榮獲「中國藥學會海洋藥物專業委員會、中國海洋湖沼學會藥物學分會」頒發的「藍十字」金杯獎； 1996年經澳門科學院發明城中心國際榮譽評定委員會評定，榮獲「 96金秋國際精品、暢銷產品及技術博覽會」國際金獎。
  4. Researchers from consumer - products companies such as est e lauder cos. and coca - cola co. of the u. s., and japanese cosmetics maker shiseido co. are increasingly mining folk medicine to create modern products and treatments

    美國的雅詩蘭黛和可口可樂等消費品公司以及資生堂等日本化妝品公司的研究人員正越來越多地從民間藥物中尋找開發日用品和保健品的靈感。
  5. Researchers surveyed 1, 662 u. s. doctors and found that 94 percent of them reported " some type of relationship with the pharmaceutical industry. " eighty - three percent of respondents reported receiving gifts of food at work, and 78 percent reported receiving free drug samples

    研究人員調查了1 ， 662個美國醫生，發現其中94 %提到「和藥品工業具有不同類型的關系「 83 %說在工作中接受食品， 78 %接受免費藥物樣品。
  6. The kerui co., ltd specially managed in the production and the sales of the medicaines, the biochemical in stallations thedairy products the drinking production line and beers the hygiene fluid fitting. our comany have made the rapid profress by the support of the social personalities of various circles and hard efforts of all the workes. we insist to rely on the sience and technology, so that we can always aboorb the experience of the internal and external advanced engineering of the medicines and the food mechanical processing, and we insist to creat boldly on the reseach and the manufacture. werec - ommend the high quality talented persons, strengthen the company inner management, go in for the market constest. positively through the flexible strategy and tactics. seek the existence by the quality serves, seek the development by the progress of the science and technology, so that we are accepted and trusted by the numerous customers, and the economic benefits progressd tapidly. out company will advanced greatly in the waves of market economy

    科瑞企業專業從事制藥生化設備乳品飲料生產線及啤酒流體配件.公司在社會各界的支持和全體員工的共同努力下.得到了迅猛發展.我們以科技為依託，吸收國內外先進制藥和食品機械加工經驗.大膽創新研製，引進優秀高素質人才.強化企業內部管理.以靈活的經營機制積極參與市場競爭，以質量服務求生存，以科技進步圖發展.贏得了廣大客戶的支持和信賴.經濟效益大幅度提高，在市場經濟大潮中不斷探索前進
  7. The company has established a close partnership with the state family planning commission to develop products for human reproductive health and with the chinese academy of medical sciences, peking union medical college to promote the development of new pharmaceutical products for cardiovascular diseases

    集團與國家計劃生育委員會合作，專門研究人類生殖健康醫藥產品；並與中國醫學科學院、中國協和醫科大學合作，投資開發心、腦血管疾病的生物醫藥項目。
  8. The international intellectual property alliance iipa is a coalition of seven trade associations representing u. s. copyright - based industries in bilateral and multilateral efforts to open up foreign markets closed by piracy and other market access barriers. these member associations represent over 1, 450 u. s. companies producing and distributing materials protected by copyright laws throughout the world - all types of computer software including business applications software and entertainment software such as videogame cds and cartridges, personal computer cds and multimedia products ; motion pictures, television programs, dvds and home videocassettes ; music, records, cds, and audiocassettes ; and textbooks, tradebooks, reference and professional publications and journals in both electronic and print media

    我們支持持續增加國家衛生研究院及其他科學機構的基礎科學研究經費；加快核準新藥的過程以盡可能讓它們快速且安全上市；透過稅負獎勵及小型企業創新研究計劃，鼓勵私人企業在研發上的投資和小型企業的發展；促進保護智慧財權及開放生技發明與產品的國際市場；建立公共資料庫，使科學家得以相互協調合作，像這樣的生技業已是大學研究人員、政府及民間產業合作的全世界最佳典範之一。
  9. In commenting on this year s special 301 process, iipa president eric h. smith noted : " the annual special 301 process is a cornerstone of the u. s. government s effort to open foreign markets closed to the u. s. copyright - based industries by high levels of piracy or market access barriers that keep out the products of the u. s. s most productive industries. it targets those countries which continue to condone high levels of piracy and other trade barriers that directly impact on u. s. jobs and economic growth. besides discussion of these barriers and ranking the countries on the traditional special 301 lists, iipa s submission also identifies the other principal priorities for the creative industries in 2001.

    我們支持持續增加國家衛生研究院及其他科學機構的基礎科學研究經費；加快核準新藥的過程以盡可能讓它們快速且安全上市；透過稅負獎勵及小型企業創新研究計劃，鼓勵私人企業在研發上的投資和小型企業的發展；促進保護智慧財權及開放生技發明與產品的國際市場；建立公共資料庫，使科學家得以相互協調合作，像這樣的生技業已是大學研究人員、政府及民間產業合作的全世界最佳典範之一。
分享友人
分享到 Line

分享到臉書